Detalhe da pesquisa
1.
The mesenchymal morphology of cells expressing the EML4-ALK V3 oncogene is dependent on phosphorylation of Eg5 by NEK7.
J Biol Chem;
300(5): 107144, 2024 May.
Artigo
em Inglês
| MEDLINE
| ID: mdl-38458397
2.
Alternative Treatment Options to ALK Inhibitor Monotherapy for EML4-ALK-Driven Lung Cancer.
Cancers (Basel);
14(14)2022 Jul 15.
Artigo
em Inglês
| MEDLINE
| ID: mdl-35884511
3.
EML4-ALK Variant 3 Promotes Mitotic Errors and Spindle Assembly Checkpoint Deficiency Leading to Increased Microtubule Poison Sensitivity.
Mol Cancer Res;
20(6): 854-866, 2022 06 03.
Artigo
em Inglês
| MEDLINE
| ID: mdl-35656694